Our analysis of HCC using the TCGA database confirmed the correlation of TKT with additional ICP genes, including CD44, CD80, CD86, and CTLA-4, which may explain the association of TKT overexpression with poorer prognoses in patients with cancer. The gene discussed is CTLA4; the disease is cancer.